Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine

The continuous evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants poses a challenge to determine the optimal updated composition of the coronavirus disease 2019 (COVID-19) vaccine. The present study aimed to investigate the immunogenicity of the Delta monovalent vacci...

Full description

Saved in:
Bibliographic Details
Main Authors: Wanting Li (Author), Tiantian Zhao (Author), Bai Tao (Author), Liwei Zhao (Author), Hang Xiao (Author), Xinyu Ding (Author), Chuang Li (Author), Lin Chen (Author), Hao Cheng (Author), Yang Lou (Author), Yuxin Chen (Author), Chao Wu (Author)
Format: Book
Published: Taylor & Francis Group, 2023-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!